NCT07134049 Sensory Integration Therapy in Children With Congenital Brachial Plexus Injury: Developmental Outcomes
| NCT ID | NCT07134049 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Obstetric Brachial Plexus Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-06-23 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-06-23 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the effectiveness of sensory integration therapy in reducing sensory, motor, and cognitive developmental impairments following Congenital Brachial Plexus Injury (CBPI), and to support the overall developmental processes of affected children.
Eligibility Criteria
Inclusion Criteria: Confirmed diagnosis of obstetric brachial plexus injury (OBPI) Age between 7 and 35 months No additional diagnosed neurological, psychiatric, and/or muscular disorders No diagnosed mental retardation or cognitive disorder that would prevent participation in assessments Written informed consent from parents or legal guardians Exclusion Criteria: Severe visual or hearing impairment preventing participation in assessments Participation in another experimental rehabilitation program within the last 3 months
Contact & Investigator
Çiğdem Öksüz, PhD, Professor,
PRINCIPAL INVESTIGATOR
Hacettepe University Faculty of Health Sciences, Department of Occupational Therapy
Frequently Asked Questions
Who can join the NCT07134049 clinical trial?
This trial is open to participants of all sexes, aged 7 Months or older, up to 35 Months, studying Obstetric Brachial Plexus Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07134049 currently recruiting?
Yes, NCT07134049 is actively recruiting participants. Contact the research team at e.ciminli19@gmail.com for enrollment information.
Where is the NCT07134049 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07134049 clinical trial?
NCT07134049 is sponsored by Hacettepe University. The principal investigator is Çiğdem Öksüz, PhD, Professor, at Hacettepe University Faculty of Health Sciences, Department of Occupational Therapy. The trial plans to enroll 30 participants.